Searched for
INDIAN DRUGMAKERS IMPACT
Govt eyes fast-tracking local production of high-end medical devicesIndia is planning to boost local manufacturing of around 10 high-value medical devices, including MRI systems and pacemakers, to curb relia...- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...
- Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: Syngene MDThe recent decision by US President Donald Trump to impose a 100 per cent tariff on patented pharmaceutical imports to US is unlikely to ca...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Trump signals major tariff on pharma imports, Indian drugmakers could face impactDonald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to relocate operations ...
- US Tariffs on pharma: What are the potential impact on Indian drugmakersUS tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal Manchanda highlight...
- Abbott India Q4 Results: Net profit rises 24% YoY on higher salesIndian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government p...
- Sun Pharma flags hypertension drug shortageIndian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs)...
- Fallout of new US labelling norms: Lawsuits from across Atlantic loomGeneric drugmakers are not meant to change their product labels until the innovator drug firm updates safety warnings on the label of its c...
- Govt not properly briefed on Glivec patent suit: DrugmakersThe case is considered to have wide implications on public health and local drug industry.
- MNC may need govt nod to buy local pharma firmMultinationals may have to move buyout proposals through FIPB, allowing the govt to understand the firm's rationale for buying a local firm.
- Wockhardt, Biocon allowed to raise Insulin prices by 18%NPPA has slashed the price of anti-asthma bulk drug used in popular brands such as Cipla's Asthalin, by 18% to Rs 3,633 per kg.
- Antibiotics may get costlierThe government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers.
- Demand for changes in patent law rejectedThe commerce, health and chemicals ministries have rejected global drugmakers controversial proposal to change key provisions of Indian pat...
- Germany's Fresenius recalls India-made drugs shipped to USGerman drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.
Load More
